PT  - JOURNAL ARTICLE
AU  - Canavan, Neil
ED  - Nout, Remi A.
TI  - Vaginal Brachytherapy for High-Intermediate Risk Endometrial Cancers
DP  - 2008 Aug 01
TA  - MD Conference Express
PG  - 12--12
VI  - 8
IP  - 4
4099  - http://mdc.sagepub.com/content/8/4/12.1.short
4100  - http://mdc.sagepub.com/content/8/4/12.1.full
AB  - Data from a randomized phase 3 trial indicate that vaginal brachytherapy (VBT) may be a better option than pelvic radiotherapy for treating high-intermediate risk (age>60 and stage 1C grade 1–2 or stage 1B grade 3; any age and stage 2A grade 1–2 or grade 3 with <50% invasion) endometrial cancers because of a lower rate of side effects, leading to enhanced quality of life. This article reports the results of the PORTEC-2 trial [NCT00376844].